Cancer

Immunologist Gabriel Rabinovich leverages his 30 years of experience studying sugar-binding proteins, galectins, for developing novel therapies.

Antibodies that simultaneously target two distinct antigens overcome cancer therapy resistance by addressing antigenic diversity and diminished T cell action. 

By directly and precisely destroying troublesome proteins, PROTAC molecules emerge as effective tools for enhancing cancer treatment.

Advanced machine learning methods generate de novo therapeutic proteins, unlocking new possibilities for more effective treatments.

Multiomics data analysis identified structural mutations in tumor genomes with important implications for cancer treatment.

Selective labeling of cancer stem cells with click chemistry-capable functional groups offers a new strategy for anticancer drug delivery.

Different precision medicine approaches modulate distinct pathways to treat cancer, but how do scientists know which approach is best?

Technological breakthroughs and innovative strategies are propelling the ongoing evolution of CAR T cell therapy. 

Screening 12,000 genes helped researchers develop new generation CAR T cells for cancer therapy.

A clearer look at chromatin structures in super resolution reveals new insights into cancer pathogenesis.

Discover the top instrument considerations for an MTT assay to improve cell viability, reproducibility, and efficiency in drug discovery.

Cells travel throughout the body, enabling diverse biological phenomena in health and disease.